Claim: S100A4 which is a member of the S100 calcium-binding protein family aids in fighting cancer.
Evidence: In vivo overexpression of S100A4 led to a significant increase in tumor growth and vascularization in a human melanoma xenograft M21 model. It is concluded that extracellular S100A4 inhibition is an attractive approach for the treatment of human cancer.